Michelle McGuinness
Corporate Officer/Principal presso Huntington's Disease Society of America
Profilo
Ms. Michelle McGuinness is VP-Regulatory Affairs & Quality Assurance at Veloxis Pharmaceuticals A/S and a Director-Southeastern Pennsylvania Chapter at Huntington's Disease Society of America.
She received her undergraduate degree from Kean University and a graduate degree from the Temple University School of Pharmacy.
Posizioni attive di Michelle McGuinness
| Società | Posizione | Inizio |
|---|---|---|
| Huntington's Disease Society of America | Corporate Officer/Principal | - |
Precedenti posizioni note di Michelle McGuinness
| Società | Posizione | Fine |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Consigliere Generale | - |
Formazione di Michelle McGuinness
| Kean University | Undergraduate Degree |
| Temple University School of Pharmacy | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
| Huntington's Disease Society of America |
- Borsa valori
- Insiders
- Michelle McGuinness
